Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 15 of the 23 sources its claims cite were checked for support.

Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

Open access
Ferrari, Sélène, Sanguinetti, Maurizio, De Bernardis, Flavia, Torelli, Riccardo, Posteraro, Brunella, Vandeputte, Patrick, Sanglard, Dominique · 2011 · Antimicrobial Agents and Chemotherapy

Abstract

Mitochondrial dysfunction is one of the possible mechanisms by which azole resistance can occur in Candida glabrata. Cells with mitochondrial DNA deficiency (so-called "petite mutants") upregulate ATP binding cassette (ABC) transporter genes and thus display increased resistance to azoles. Isolation of such C. glabrata mutants from patients receiving antifungal therapy or prophylaxis has been rarely reported. In this study, we characterized two sequential and related C. glabrata isolates recovered from the same patient undergoing azole therapy. The first isolate (BPY40) was azole susceptible (fluconazole MIC, 4 μg/ml), and the second (BPY41) was azole resistant (fluconazole MIC, >256 μg/ml). BPY41 exhibited mitochondrial dysfunction and upregulation of the ABC transporter genes C. glabrata CDR1 (CgCDR1), CgCDR2, and CgSNQ2. We next assessed whether mitochondrial dysfunction conferred a selective advantage during host infection by testing the virulence of BPY40 and BPY41 in mice. Surprisingly, even with in vitro growth deficiency compared to BPY40, BPY41 was more virulent (as judged by mortality and fungal tissue burden) than BPY40 in both systemic and vaginal murine infection models. The increased virulence of the petite mutant correlated with a drastic gain of fitness in mice compared to that of its parental isolate. To understand this unexpected feature, genome-wide changes in gene expression driven by the petite mutation were analyzed by use of microarrays during in vitro growth. Enrichment of specific biological processes (oxido-reductive metabolism and the stress response) was observed in BPY41, all of which was consistent with mitochondrial dysfunction. Finally, some genes involved in cell wall remodelling were upregulated in BPY41 compared to BPY40, which may partially explain the enhanced virulence of BPY41. In conclusion, this study shows for the first time that mitochondrial dysfunction selected in vivo under azole therapy, even if strongly affecting in vitro growth characteristics, can confer a selective advantage under host conditions, allowing the C. glabrata mutant to be more virulent than wild-type isolates.

Overview

CoChat Summary

TL;DR

A clinical *Candida glabrata* petite mutant (BPY41) that arose after azole therapy was azole resistant and, despite in vitro growth deficiency, was more virulent and fitter than its azole-susceptible parent (BPY40) in murine systemic and rat vaginal infection models. An in vitro-generated petite mutant (DSY4339) did not show this enhanced virulence, suggesting the origin/selection context of mitochondrial dysfunction matters.

Key findings

  • BPY41 was azole resistant (fluconazole MIC >256 μg/ml) versus BPY40 (fluconazole MIC 4 μg/ml), with cross-resistance to itraconazole and voriconazole, and overexpressed *CgCDR1*, *CgCDR2*, *CgSNQ2*, and *CgPDR1* without a detected *CgPDR1* mutation.
  • BPY41 showed mitochondrial dysfunction: no growth on glycerol, absent SYTO18 mitochondrial staining, no recoverable mitochondrial DNA, and strongly reduced oxygen consumption.
  • BPY41 was more virulent than BPY40 in mice: lower LD50s (BPY41 3.45 × 10^7 CFU immunocompetent and 2.3 × 10^7 CFU immunosuppressed vs. BPY40 7.2 × 10^7 and 6.8 × 10^7 CFU), higher tissue burdens in kidney, spleen, and liver at day 7, and slower vaginal clearance in rats.
  • The in vitro-generated petite DSY4339 had higher LD50s (2.81 × 10^8 CFU immunocompetent and 1.65 × 10^8 CFU immunosuppressed) and lowest tissue burdens, with virulence not significantly different from BPY40.

Methods

  • Two sequential related clinical *C. glabrata* isolates from the same patient were studied: BPY40 (azole-susceptible parent) and BPY41 (azole-resistant petite mutant); DSY4339 was generated in vitro from BPY40 by ethidium bromide exposure.
  • Murine systemic infection models used female BALB/c mice for survival, LD50 determination, and tissue burden (liver, spleen, kidney); a rat vaginal mucosa infection model used oophorectomized female Wistar rats. In vitro and in vivo fitness competitions mixed BPY40 and BPY41 and distinguished them by growth on fluconazole.
  • Genome-wide expression was analyzed by custom *C. glabrata* Agilent microarrays with three biological replicates; genes were included if expression changed at least 2-fold between BPY41 and BPY40 in at least two independent experiments with corrected *P* < 0.05. qRT-PCR measured *CgCDR1*, *CgCDR2*, *CgSNQ2*, *CgPDR1*, and *CgYPS*.

Limitations

  • The paper states it cannot exclude that the in vitro- or in vivo-generated mitochondrial mutants also contain nuclear mutations that decrease or increase virulence, respectively.
  • The paper notes that the exact regulatory mechanisms behind ABC transporter upregulation in petite mutants remain largely unresolved.
  • The provided text is truncated in the Results, so later analyses and the full discussion are not available here; the paper’s statement beginning “Our current data cannot confirm…” is cut off.

Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/aac.01271-10

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

12 Valid · 1 Not valid · 5 Not checked · 18 Own results and interpretations

18 more claims · 1 with their cited sources checked

Create a free account to see all 36 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 7

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

14 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 44 references

Cited by

See all 145

Metadata

Authors
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D.
Affiliations
  • University of Lausanne (CH)
  • Università Cattolica del Sacro Cuore (IT)
  • Department of Infectious, Parasitic, and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
Venue
Antimicrobial Agents and Chemotherapy
Published
2011-05
Volume
55
Issue
5
Pages
1852-1860
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2098964280
Cited by
144
References
44
Citations by year
2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 8 · 2021: 7 · 2020: 9 · 2019: 12 · 2018: 12 · 2017: 12 · 2016: 5 · 2015: 5 · 2014: 9 · 2013: 12 · 2012: 12
FWCI
8.64
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida glabrata, azole resistance, mitochondrial dysfunction, petite mutants, ABC transporters, CDR1, CDR2, fluconazole, fungal virulence, antifungal therapy, cell wall remodeling, oxidative stress response, gene expression profiling, fitness cost
MeSH terms
Animals, Azoles, Female, Mice, Inbred BALB C, Microbial Sensitivity Tests, Molecular Sequence Data, Virulence, Gene Expression Regulation, Fungal, Computational Biology, Reverse Transcriptase Polymerase Chain Reaction, Drug Resistance, Fungal, Candida glabrata, Microarray Analysis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice. https://app.cochat.ai/papers/10.1128/aac.01271-10
The paper
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011). Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01271-10

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.